News

Mizuho Boosts DraftKings Stock Target on Earnings Outlook

Mizuho Boosts DraftKings Stock Target on Earnings Outlook

Mizuho’s Upbeat Outlook for DraftKings

Recently, Mizuho Securities showcased their confidence in DraftKings Inc. (NASDAQ: DKNG) by elevating its price target to $62.00, an increase from the prior target of $54.00. This adjustment comes alongside maintaining an Outperform rating, indicating a strong belief in the company’s potential to meet and potentially exceed its future earnings before interest, taxes, depreciation, and amortization (EBITDA) forecasts for the years 2025, 2026, and 2028.

The Underestimated Potential

Mizuho's findings reveal that the long-term earnings potential of DraftKings is currently underappreciated in the market. The firm’s analyst pointed out key areas where significant operating leverage can be realized, suggesting that the market has yet to fully grasp the company's broader growth narrative. Short-term market fluctuations, such as game outcomes and month-to-month revenue changes, seem to overshadow the overall growth potential of DraftKings.

Near and Medium-Term Promises

Additionally, the outlook for DraftKings over the near and medium term appears promising, especially considering what the analyst describes as "particularly easy hold comparisons" relative to previous months. This advantageous comparison could contribute to an upside in the company’s revenue projections, which could further validate Mizuho's optimistic stance on DraftKings.

Inclusion in Mizuho's Top Picks

In a significant endorsement of DraftKings, it has been included in Mizuho's Top Picks list. This decision stems from an in-depth analysis of both medium and long-term variables anticipated to drive the company’s earnings growth. The analyst's perspective indicates that DraftKings has strong foundational elements that could see it flourish in the evolving market landscape.

Recent Performance Highlights

DraftKings recently reported an impressive 80% year-over-year increase in new customers for online sports betting and iGaming, paired with a remarkable 26% rise in overall revenue, reaching $1.104 billion. Notably, the company achieved a significant reduction of over 40% in its marketing costs and announced a proactive share repurchase program valued up to $1 billion. On the regulatory side, DraftKings has agreed to a $200,000 penalty to the U.S. Securities and Exchange Commission (SEC) related to charges of failing to disclose essential non-public information to investors adequately.

Analysts' Support

Several analysts have voiced their favorable outlook regarding DraftKings. BMO Capital Markets reiterated its Outperform rating with a price target of $48, despite addressing potential challenges from recent tax legislation. Susquehanna also increased the price target to $50 after anticipating a strong third-quarter outlook. Additionally, JPMorgan has upped its target for DraftKings to $54, maintaining an Overweight rating, while Needham kept its Buy rating consistent with a price target of $60, even after slightly adjusting EBITDA projections for upcoming years.

Insights and Growth Metrics

The encouraging outlook from Mizuho aligns with key metrics and insights regarding DraftKings’ performance. Recent figures show a robust revenue growth of 43.26% over the last twelve months as of Q2 2024, complemented by a quarterly growth of 26.23% in that same period. These strong performance indicators bolster Mizuho's assertion regarding the company’s growth trajectory.

Future Profitability Predictions

While DraftKings currently operates with a moderate level of debt and is not profitable yet, analysts predict an upward shift toward profitability within this year. This projection corresponds with Mizuho's view regarding the previously overlooked long-term earnings potential of the company. DraftKings has shown a high return over the last decade, alongside a strong return in the last five years, which reinforces a positive sentiment among investors.

Frequently Asked Questions

What is Mizuho's new price target for DraftKings?

Mizuho's new price target for DraftKings is set at $62.00, up from $54.00.

Why does Mizuho believe DraftKings has underestimated earnings potential?

Mizuho believes that market focus on short-term fluctuations has overshadowed DraftKings' significant long-term growth prospects and operating leverage.

What recent performance metrics support DraftKings’ growth?

DraftKings reported an 80% increase in new customers year-over-year and a revenue rise of 26%, totaling $1.104 billion.

How are analysts responding to DraftKings' performance?

Analysts from various firms have maintained or increased their price targets and ratings, reflecting a positive outlook on DraftKings' growth trajectory.

What is the outlook for DraftKings regarding profitability?

Analysts predict that DraftKings will achieve profitability this year, aligning with Mizuho's assessment of its long-term earnings potential.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Why Ghosts Don’t Spook Homebuyers Anymore

Updated Category News Views 145

Haunted Houses—A New Norm in Real Estate? In what's becoming a spooky trend in real estate, more than half of Americans are game for buying haunted houses. Imagine that! Suddenly, Casper and his ghostly pals are claiming space in the housing market. With home prices soaring, folks are getting creative. Could a phantasmal presence really tip the scales for cash-strapped...

Continue Reading
Flex LNG Readies for Crucial Q3 Earnings Reveal

Updated Category News Views 74

Anticipation Builds for Flex LNG's Upcoming Q3 Reveal The air's thick with expectation as Flex LNG gears up to lay its cards on the table for the third quarter of 2026. Come November 11, the company will spill the beans on its financial dance over the last few months, promising to unfurl the numbers early in the morning like a farmer checking crops at dawn—07:00 CET...

Continue Reading
JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 131

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Proton Therapy: A Game-changer in Breast Cancer Treatment

Updated Category News Views 53

Understanding the Radiation Conundrum When it comes to breast cancer, there's no sugarcoating it—the diagnosis alone can shake the foundation of anyone's life. But once the dust settles, another layer of decisions begins. One of the trickiest questions patients face is, "What radiation options are out there?" That's where proton therapy comes in, and it's high time we...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
Bluevua Partners with Orlando Solar Bears

Updated Category News Views 56

Bluevua Takes Aim at Bigger Waters Bluevua's move to partner with the Orlando Solar Bears ain't just some casual sponsorship. It’s a statement, loud and clear, that they're ready to play in the big leagues. By sliding into this relationship, they’re not only flexing their branding muscles but also tapping into a vibrant sports market. It’s a clever game plan to...

Continue Reading
Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 145

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
PZZA Faces Class Action Over Misleading Sales Outlook

Updated Category News Views 22

Who's Pointing Fingers at Papa John's? Papa John's International, Inc. (NASDAQ: PZZA) is now headlining a courtroom drama that sounds as crispy as their pizza crust. Last ditch deadline's pinned for November 2, 2026, for grabbing the top spot as lead plaintiff against Papa John’s top brass, Todd Allan Penegor and former CFO Ravi Thanawala. These head honchos reportedly...

Continue Reading
Heritage Wines Meet Non-Alcoholic Trend: New Deal

Updated Category News Views 57

Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...

Continue Reading

Top 5 Most Recently Viewed Articles

Ketel One Vodka and Dorsia Unite for a Night of Elegance

Updated Category News Views 325

Ketel One and Dorsia's Exclusive Collaboration Ketel One Family Made Vodka is thrilled to announce an extraordinary partnership with Dorsia, a standout leader in hospitality and technology. This collaboration aims to bring to life the allure of the famed fictional restaurant, Dorsia, for an exciting evening that diners won't forget. The event will unite those who...

Continue Reading
Hubexo Emerges as a Leader in Global Construction Innovation

Updated Category News Views 723

Hubexo Rebranding: A New Era for Construction Hubexo, previously known as Byggfakta Group, has embarked on an exciting journey of transformation in the global construction industry. This name change by the parent company signifies their commitment to innovative approaches and growth within the construction data sector. As Hubexo, the company aims to be at the forefront,...

Continue Reading
Medidata Unveils Rave Lite Revolutionizing Clinical Trials

Updated Category News Views 236

Medidata Launches Rave Lite for Enhanced Clinical Trials Medidata, a prominent brand under Dassault Systèmes, is making waves in the clinical trial sector with its latest innovation, Rave Lite. This cutting-edge solution is tailored to support both early and late-stage clinical trials, elevating the standards of efficiency and effectiveness in electronic data capture and...

Continue Reading
Campfire Secures $65 Million in Series B Funding for AI Finance

Updated Category News Views 374

Campfire's Groundbreaking Series B Funding Round Recently, Campfire made headlines by securing a substantial $65 million in its Series B funding round. This impressive achievement contributes to a total funding of over $100 million raised in just 12 weeks, showcasing the rapid growth and increasing interest in AI-driven operations within finance teams. The Driving Forces...

Continue Reading
Understanding Market Sentiments in United Airlines Options Trading

Updated Category News Views 164

Understanding Options Trading Activity for United Airlines Holdings In recent trading sessions, there has been significant activity among options for United Airlines Holdings. Our analysis uncovered that 19 unusual option trades occurred, reflecting trends and sentiments from various market participants. Market Participants' Sentiments Upon evaluating the trades, it was...

Continue Reading